Terms: = Head and neck cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
93 results:
1. hsp90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.
Chen F; Tang C; Yang F; Ekpenyong A; Qin R; Xie J; Momen-Heravi F; Saba NF; Teng Y
Sci Adv; 2024 Feb; 10(8):eadk3663. PubMed ID: 38394204
[TBL] [Abstract] [Full Text] [Related]
2. PER2 binding to hsp90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK/NF-κB pathway and PD-L1 expression.
Zhang Z; Sun D; Tang H; Ren J; Yin S; Yang K
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37914384
[TBL] [Abstract] [Full Text] [Related]
3. Synergistic effect of hsp90 inhibitor ginkgolic acids C15
Ma H; Huang D; Li B; Ding F; Li H; Wu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1128-1135. PubMed ID: 37875353
[TBL] [Abstract] [Full Text] [Related]
4. Combination therapy of tyrosine kinase inhibitor sorafenib with the hsp90 inhibitor onalespib as a novel treatment regimen for thyroid cancer.
Mortensen ACL; Berglund H; Hariri M; Papalanis E; Malmberg C; Spiegelberg D
Sci Rep; 2023 Oct; 13(1):16844. PubMed ID: 37803074
[TBL] [Abstract] [Full Text] [Related]
5. Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin's suppression of oral cancer.
Dong H; Li M; Chen H; Tian L; Wei W; Wang S; Cheng G; Liu S
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15055-15067. PubMed ID: 37610675
[TBL] [Abstract] [Full Text] [Related]
6. hsp90aa1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition.
Tang F; Li Y; Pan M; Wang Z; Lu T; Liu C; Zhou X; Hu G
Oncol Res; 2023; 31(5):787-803. PubMed ID: 37547757
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA FAS-AS1 upregulated by its genetic variation rs6586163 promotes cell apoptosis in nasopharyngeal carcinoma through regulating mitochondria function and Fas splicing.
Guo Z; Li Z; Zhang M; Bao M; He B; Zhou X
Sci Rep; 2023 May; 13(1):8218. PubMed ID: 37217794
[TBL] [Abstract] [Full Text] [Related]
8. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma.
Fu Y; Liang X; Yang X; Liu J; Huang H; Zhang P; Li S; Zhu D; Zhang Y; Peng F; Chen Y; Chen Z
Mol Cell Proteomics; 2023 Jun; 22(6):100567. PubMed ID: 37172717
[TBL] [Abstract] [Full Text] [Related]
9. Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression.
Feng R; Yin Y; Wei Y; Li Y; Li L; Zhu R; Yu X; Liu Y; Zhao Y; Liu Z
Cancer Lett; 2023 May; 562():216154. PubMed ID: 37030635
[TBL] [Abstract] [Full Text] [Related]
10. Network Pharmacological Study of Compound Kushen Injection in Esophageal cancer.
Guo D; Jin J; Liu J; Ren M; He Y
Curr Comput Aided Drug Des; 2023; 19(5):367-381. PubMed ID: 36635923
[TBL] [Abstract] [Full Text] [Related]
11. Fisetin, a dietary flavonoid, increases the sensitivity of chemoresistant head and neck carcinoma cells to cisplatin possibly through hsp90aa1/IL-17 pathway.
Ling J; Zhang L; Wang Y; Chang A; Huang Y; Zhao H; Zhuo X
Phytother Res; 2023 May; 37(5):1997-2011. PubMed ID: 36631292
[TBL] [Abstract] [Full Text] [Related]
12. Cisplatin-induced HSF1-hsp90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma.
Sasaya T; Kubo T; Murata K; Mizue Y; Sasaki K; Yanagawa J; Imagawa M; Kato H; Tsukahara T; Kanaseki T; Tamura Y; Miyazaki A; Hirohashi Y; Torigoe T
Cancer Med; 2023 Feb; 12(4):4605-4615. PubMed ID: 36200687
[TBL] [Abstract] [Full Text] [Related]
13. The Chaperone System in Salivary Glands: hsp90 Prospects for Differential Diagnosis and treatment of Malignant Tumors.
Basset CA; Rappa F; Barone R; Florena AM; Porcasi R; Conway de Macario E; Macario AJL; Leone A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012578
[TBL] [Abstract] [Full Text] [Related]
14. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373
[TBL] [Abstract] [Full Text] [Related]
15. Lentinan Enhances the Function of Oxaliplatin on the Esophageal Tumors by Persuading Immunogenic Cell Death.
Huo X; Pei Z; Wang W; Liu Y; Sun J; Wang H; Ai N
Comput Math Methods Med; 2022; 2022():2296574. PubMed ID: 35844448
[TBL] [Abstract] [Full Text] [Related]
16. Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial.
Kurokawa Y; Honma Y; Sawaki A; Naito Y; Iwagami S; Komatsu Y; Takahashi T; Nishida T; Doi T
Ann Oncol; 2022 Sep; 33(9):959-967. PubMed ID: 35688358
[TBL] [Abstract] [Full Text] [Related]
17. hsp90/IKK-rich small extracellular vesicles activate pro-angiogenic melanoma-associated fibroblasts via the NF-κB/CXCL1 axis.
Tang H; Zhou X; Zhao X; Luo X; Luo T; Chen Y; Liang W; Jiang E; Liu K; Shao Z; Shang Z
Cancer Sci; 2022 Apr; 113(4):1168-1181. PubMed ID: 35043517
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis.
Ye B; Fan D; Xiong W; Li M; Yuan J; Jiang Q; Zhao Y; Lin J; Liu J; Lv Y; Wang X; Li Z; Su J; Qiao Y
Nat Commun; 2021 Jul; 12(1):4457. PubMed ID: 34294701
[TBL] [Abstract] [Full Text] [Related]
19. Identification of Heat Shock Protein 90 as a Recurrence Related Marker in Juvenile Nasopharyngeal Angiofibroma.
Wang J; Hu L; Liu Z; Wang H; Zhang H; Song X; Sun X; Wang D
Am J Rhinol Allergy; 2022 Jan; 36(1):8-17. PubMed ID: 33940949
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Chaperones and Thyroid cancer.
Paladino L; Vitale AM; Santonocito R; Pitruzzella A; Cipolla C; Graceffa G; Bucchieri F; Conway de Macario E; Macario AJL; Rappa F
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919591
[TBL] [Abstract] [Full Text] [Related]
[Next]
